Flavonoids, a ubiquitous dietary phenolic subclass, exert extensive in vitro anti-invasive and in vivo anti-metastatic activities

Cancer and Metastasis Reviews

Volumn 31, Issue 1-2, 2012, Pages 323-351

  Weng, Chia Jui ^a   Yen, Gow Chin ^b  

^a TAINAN UNIVERSITY OF TECHNOLOGY   (Taiwan)

^b NATIONAL CHUNG HSING UNIVERSITY   (Taiwan)

Author keywords

Angiogenesis; Chemoprevention; Flavonoid; Invasion; Metastasis

Indexed keywords

ANTHOCYANIN; ANTIMETASTATIC AGENT; APIGENIN; CATENIN; CYTOKERATIN 18; DAIDZEIN; DAIDZIN; EPICATECHIN; EPICATECHIN GALLATE; EPIGALLOCATECHIN; EPIGALLOCATECHIN GALLATE; FLAVONOID; FLAVONOL; GENISTEIN; GENISTIN; GLYCITEIN; ISOFLAVONE; KAEMPFEROL; LUTEOLIN; MYRICETIN; NARINGENIN; NERVE CELL ADHESION MOLECULE; QUERCETIN; SILIBININ; TANGERETIN; TRANSCRIPTION FACTOR SLUG; TRANSCRIPTION FACTOR SNAIL; UNINDEXED DRUG; UVOMORULIN; VIMENTIN;

ANGIOGENESIS; ANTIANGIOGENIC ACTIVITY; ANTINEOPLASTIC ACTIVITY; BILIARY TRACT CANCER; BRAIN CANCER; BREAST CANCER; CANCER CELL; CANCER CELL CULTURE; CANCER DIAGNOSIS; CANCER GROWTH; CANCER INVASION; CELL ADHESION; CELL MOTILITY; COLON CANCER; DRUG EFFECT; EPITHELIAL MESENCHYMAL TRANSITION; FIBROSARCOMA; GENETIC TRANSCRIPTION; HUMAN; HYPOPHARYNX CANCER; IN VITRO STUDY; IN VIVO STUDY; INTESTINE CANCER; KAPOSI SARCOMA; KIDNEY CANCER; LIVER CANCER; LUNG CANCER; MELANOMA; METASTASIS INHIBITION; MOUTH CANCER; NONHUMAN; OSTEOSARCOMA; OVARY CANCER; PANCREAS CANCER; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN BINDING; PROTEIN EXPRESSION; REVIEW; STOMACH CANCER; THYROID CANCER; UTERINE CERVIX CANCER;

ANIMALS; DIET; FLAVONOIDS; HUMANS; MICE; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS;

EID: 84862309686     PISSN: 01677659     EISSN: 15737233     Source Type: Journal    
DOI: 10.1007/s10555-012-9347-y     Document Type: Review

References (237)

1. Weiss, L. (1990). Metastatic inefficiency. Advances in Cancer Research, 54, 159-211.
2. Liotta, L. A., Steeg, P. S., & Stetter-Stevenson, W. G. (1991). Cancer metastasis and angiogenesis: An imbalance of positive and negative regulation. Cell, 64, 327-336. (Pubitemid 121001258)
3. Condeelis, J., & Segall, J. E. (2003). Intravital imaging of cell movement in tumours. Nature Reviews. Cancer, 3, 921-930. (Pubitemid 37500177)
4. Van Sumere, C. F. (1989). Phenols and phenolic acids. In J. B. Harborne (Ed.), Methods in plant biochemistry, volume 1 (Plant phenolics, pp. 29-74). London: Academic.
5. Shahidi, F. (2000). Antioxidants in food and food antioxidants. Die Nahrung, 44, 158-163.
6. Shahidi, F. (2002). Antioxidants in plants and oleaginous seeds. In M. J. Morello, F. Shahidi, & C. T. Ho (Eds.), Free radicals in food: Chemistry, nutrition, and health effects, ACS symposium series 807 (pp. 162-175). Washington, DC: American Chemical Society.
7. Cook, N. C., & Samman, S. (1996). Flavonoids-chemistry, metabolism, cardioprotective effects, and dietary sources. The Journal of Nutritional Biochemistry, 7, 66-76. (Pubitemid 26086316)
8. Ververidis, F., Trantas, E., Douglas, C., Vollmer, G., Kretzschmar, G., & Panopoulos, N. (2007). Biotechnology of flavonoids and other phenylpropanoid-derived natural products. Part I: Chemical diversity, impacts on plant biology and human health. Biotechnology Journal, 2, 1214-1234. (Pubitemid 350047840)
9. Sliva, D. (2008). Suppression of cancer invasiveness by dietary compounds. Mini Reviews in Medicinal Chemistry, 8, 677-688.
10. Weng, C. J., & Yen, G. C. (2012). Chemopreventive effects of dietary phytochemicals against cancer invasion and metastasis: Phenolic acids, monophenol, polyphenol, and their derivatives. Cancer Treatment Reviews, 38, 76-87.
11. Christofori, G. (2006). New signals from the invasive front. Nature, 441, 444-450.
12. Thiery, J. P. (2002). Epithelial-mesenchymal transitions in tumour progression. Nature Reviews. Cancer, 2, 442-454.
13. Yang, J., & Weinberg, R. A. (2008). Epithelial-mesenchymal transition: At the crossroads of development and tumor metastasis. Developmental Cell, 14, 818-829. (Pubitemid 351757205)
14. Joo, Y., Rew, J., Park, C., & Kim, S. (2002). Expression of Ecadherin, alpha- and beta-catenins in patients with pancreatic adenocarcinoma. Pancreatology, 2, 129-137. (Pubitemid 34639088)
15. Nakajima, S., Doi, R., Toyoda, E., Tsuji, S., Wada, M., Koizumi, M., Tulachan, S. S., Ito, D., Kami, K., Mori, T., Kawaguchi, Y., Fujimoto, K., Hosotani, R., & Imamura, M. (2004). N-cadherin expression and epithelial-mesenchymal transition in pancreatic carcinoma. Clinical Cancer Research, 10, 4125-4133. (Pubitemid 38812492)
16. Sanders, D. S., Bruton, R., Darnton, S. J., Casson, A. G., Hanson, I.,Williams, H. K., & Jankowski, J. (1998). Sequential changes in cadherin-catenin expression associated with the progression and heterogeneity of primary oesophageal squamous carcinoma. International Journal of Cancer, 79, 573-579. (Pubitemid 28549467)
17. Muzio, L. Lo, Pannone, G., Mignogna, M. D., Staibano, S., Mariggio, M. A., Rubini, C., Procaccini, M., Dolci, M., Bufo, P., Rosa, G. De, & Piattelli, A. (2004). P-cadherin expression predicts clinical outcome in oral squamous cell carcinomas. Histology and Histopathology, 19, 1089-1099. (Pubitemid 39386766)
18. Bachmann, I. M., Straume, O., Puntervoll, H. E., Kalvenes, M. B., & Akslen, L. A. (2005). Importance of P-cadherin, betacatenin, and Wnt5a/frizzled for progression of melanocytic tumors and prognosis in cutaneous melanoma. Clinical Cancer Research, 11, 8606-8614. (Pubitemid 43005907)
19. Van Marck, V., Stove, C., Jacobs, K., Van den Eynden, G., & Bracke, M. (2011). P-cadherin in adhesion and invasion: Opposite roles in colon and bladder carcinoma. International Journal of Cancer, 128, 1031-1044.
20. Gamallo, C., Moreno-Bueno, G., Sarrio, D., Calero, F., Hardisson, D., & Palacios, J. (2001). The prognostic significance of P-cadherin in infiltrating ductal breast carcinoma. Modern Pathology, 14, 650-654. (Pubitemid 32667208)
21. Paredes, J., Stove, C., Stove, V., Milanezi, F., Van Marck, V., Derycke, L., Mareel, M., Bracke, M., & Schmitt, F. (2004). Pcadherin is upregulated by the antiestrogen ICI 182,780 and promotes invasion of human breast cancer cells. Cancer Research, 64, 8309-8317. (Pubitemid 39491769)
22. Stefansson, I. M., Salvesen, H. B., & Akslen, L. A. (2004). Prognostic impact of alterations in Pcadherin expression and related cell adhesion markers in endometrial cancer. Journal of Clinical Oncology, 22, 1242-1252. (Pubitemid 41079838)
23. Taniuchi, K., Nakagawa, H., Hosokawa,M., Nakamura, T., Eguchi, H., Ohigashi, H., Ishikawa, O., Katagiri, T.,&Nakamura, Y. (2005). Overexpressed P-cadherin/CDH3 promotes motility of pancreaticcancer cells by interacting with p120ctn and activating rho-family GTPases. Cancer Research, 65, 3092-3099. (Pubitemid 40524589)
24. Gravdal, K., Halvorsen, O. J., Haukaas, S. A., & Akslen, L. A. (2007). A switch from E-cadherin to N-cadherin expression indicates epithelial to mesenchymal transition and is of strong and independent importance for the progress of prostate cancer. Clinical Cancer Research, 13, 7003-7011. (Pubitemid 350276881)
25. Tothill, R. W., Tinker, A. V., George, J., Brown, R., Fox, S. B., Lade, S., Johnson, D. S., Trivett, M. K., Etemadmoghadam, D., Locandro, B., Traficante, N., Fereday, S., Hung, J. A., Chiew, Y. E., Haviv, I., Australian Ovarian Cancer Study Group, Gertig, D., DeFazio, A., & Bowtell, D. D. (2008). Novel molecular subtypes of serous and endometrioid ovarian cancer linked to clinical outcome. Clinical Cancer Research, 14, 5198-5208.
26. Imai, K., Hirata, S., Irie, A., Senju, S., Ikuta, Y., Yokomine, K., Harao, M., Inoue, M., Tsunoda, T., Nakatsuru, S., Nakagawa, H., Nakamura, Y., Baba, H., & Nishimura, Y. (2008). Identification of a novel tumor-associated antigen, cadherin 3/P-cadherin, as a possible target for immunotherapy of pancreatic, gastric, and colorectal cancers. Clinical Cancer Research, 14, 6487-6495.
27. Francí, C., Takkunen, M., Dave, N., Alameda, F., Gómez, S., Rodríguez, R., Escrivà,M.,Montserrat-Sentís, B., Baró, T., Garrido, M., Bonilla, F., Virtanen, I., & García de Herreros, A. (2006). Expression of Snail protein in tumor-stroma interface. Oncogene, 25, 5134-5144.
28. Hipp, S., Walch, A., Schuster, T., Höfler, H., & Becker, K. F. (2008). Precise measurement of the E-cadherin repressor Snail in formalin-fixed endometrial carcinoma using protein lysate microarrays. Clinical & Experimental Metastasis, 25, 679-683.
29. Burk, U., Schubert, J., Wellner, U., Schmalhofer, O., Vincan, E., Spaderna, S., & Brabletz, T. (2008). A reciprocal repression between ZEB1 and members of the miR-200 family promotes EMT and invasion in cancer cells. EMBO Reports, 9, 582-589. (Pubitemid 351772923)
30. Chang, T. H., Tsai,M. F., Su, K. Y.,Wu, S. G., Huang, C. P., Yu, S. L., Yu, Y. L., Lan, C. C., Yang, C. H., Lin, S. B.,Wu, C. P., Shih, J. Y., & Yang, P. C. (2011). Slug confers resistance to the epidermal growth factor receptor tyrosine kinase inhibitor. American Journal of Respiratory and Critical Care Medicine, 183, 1071-1079.
31. Myatt, S. S., & Lam, E.W. (2007). The emerging roles of forkhead box (Fox) proteins in cancer. Nature Reviews. Cancer, 7, 847-859. (Pubitemid 350006253)
32. Humphries, M. J. (2000). Integrin structure. Biochemical Society Transactions, 28, 311-339.
33. Yamamoto, M., Bharti, A., Li, Y., & Kufe, D. (1997). Interaction of the DF3/MUC1 breast carcinoma-associated antigen and betacatenin in cell adhesion. Journal of Biological Chemistry, 272, 12492-12494. (Pubitemid 27203339)
34. Huang, L., Chen, D., Liu, D., Yin, L., Kharbanda, S., & Kufe, D. (2005). MUC1 oncoprotein blocks glycogen synthase kinase 3beta-mediated phosphorylation and degradation of betacatenin. Cancer Research, 65, 10413-10422. (Pubitemid 41743735)
35. Roy, L. D., Sahraei, M., Subramani, D. B., Besmer, D., Nath, S., Tinder, T. L., Bajaj, E., Shanmugam, K., Lee, Y. Y., Hwang, S. I. L., Gendler, S. J., & Mukherjee, P. (2011). MUC1 enhances invasiveness of pancreatic cancer cells by inducing epithelial to mesenchymal transition. Oncogene, 30, 1449-1459.
36. Sahai, E. (2007). Illuminating the metastatic process. Nature Reviews. Cancer, 7, 737-749.
37. Wyckoff, J. B., Jones, J. G., Condeelis, J. S., & Segall, J. E. (2000). A critical step in metastasis: In vivo analysis of intravasation at the primary tumor. Cancer Research, 60, 2504-2511. (Pubitemid 30262445)
38. Ghosh, M., Song, X., Mouneimne, G., Sidani, M., Lawrence, D. S., & Condeelis, J. S. (2004). Cofilin promotes actin polymerization and defines the direction of cell motility. Science, 304, 743-746. (Pubitemid 38560882)
39. Kleiner, D. E., & Stetler-Stevenson, W. G. (1999). Matrix metalloproteinases and metastasis. Cancer Chemotherapy and Pharmacology, 43, S41-S51.
40. Westermarck, J., & Kahari, V. M. (1999). Regulation of matrix metalloproteinase expression in tumor invasion. The FASEB Journal, 13, 781-792. (Pubitemid 29220691)
41. Friedl, P., & Wolf, K. (2003). Tumour-cell invasion and migration: Diversity and escape mechanisms. Nature Reviews. Cancer, 3, 362-374. (Pubitemid 37328856)
42. Rao, J. S. (2003). Molecular mechanisms of glioma invasiveness: The role of proteases. Nature Reviews. Cancer, 3, 489-501.
43. Yamamoto, H., Itoh, F., Iku, S., Adachi, Y., Fukushima, H., Sasaki, S., Mukaiya, M., Hirata, K., & Imai, K. (2001). Expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in human pancreatic adenocarcinomas: Clinicopathologic and prognostic significance of matrilysin expression. Journal of Clinical Oncology, 19, 1118-1127. (Pubitemid 32176289)
44. Chung, T.W.,Moon, S.K., Lee, Y. C., Kim, J. G., Ko, J. H.,&Kim, C. H. (2002). Enhanced expression of matrix metalloproteinase-9 by hepatitis B virus infection in liver cells. Archives of Biochemistry and Biophysics, 408, 147-154.
45. Muramatsu, T., & Miyauchi, T. (2004). Basigin (CD147): A multifunctional transmembrane protein involved in reproduction, neural function, inflammation and tumor invasion. Histology and Histopathology, 18, 981-987. (Pubitemid 36773240)
46. Jinga, D. C., Blidaru, A., Condrea, I., Ardeleanu, C., Dragomir, C., Szegli, G., Stefanescu, M., & Matache, C. (2006). MMP-9 and MMP-2 gelatinases and TIMP-1 and TIMP-2 inhibitors in breast cancer: Correlations with prognostic factors. Journal of Cellular and Molecular Medicine, 10, 499-510. (Pubitemid 44872701)
47. Tan, X., Egami, H., Nozawa, F., Abe, M., & Baba, H. (2006). Analysis of the invasion-metastasis mechanism in pancreatic cancer: Involvement of plasmin(ogen) cascade proteins in the invasion of pancreatic cancer cells. International Journal of Oncology, 28, 369-374.
48. Mazar, A. P. (2001). The urokinase plasminogen activator receptor (uPAR) as a target for the diagnosis and therapy of cancer. Anti-Cancer Drugs, 12, 387-400.
49. Sliva, D., Labarrere, C., Slivova, V., Sedlak, M., Lloyd, F. P., Jr., & Ho, N. W. (2002). Ganoderma lucidum suppresses motility of highly invasive breast and prostate cancer cells. Biochemical and Biophysical Research Communications, 298, 603-612. (Pubitemid 35333701)
50. Sidenius, N., & Blasi, F. (2003). The urokinase plasminogen activator system in cancer: Recent advances and implication for prognosis and therapy. Cancer and Metastasis Reviews, 22, 205-222. (Pubitemid 36561058)
51. Han, B., Nakamura, M., Mori, I., Nakamura, Y., & Kakudo, K. (2005). Urokinase-type plasminogen activator system and breast cancer (review). Oncology Reports, 14, 105-112.
52. Duggan, C., Kennedy, S., Kramer, M. D., Barnes, C., Elvin, P., McDermott, E., O'Higgins, N., & Duffy, M. J. (1997). Plasminogen activator inhibitor type 2 in breast cancer. British Journal of Cancer, 76, 622-627. (Pubitemid 27354676)
53. Sakakibara, T., Hibi, K., Koike, M., Fujiwara, M., Kodera, Y., Ito, K., & Nakao, A. (2005). Plasminogen activator inhibitor-1 as a potential marker for the malignancy of colorectal cancer. British Journal of Cancer, 93, 799-803. (Pubitemid 41486440)
54. Kang, H. G., Kim, H. S., Kim, K. J., Oh, J. H., Lee, M. R., Seol, S. M., & Han, I. (2007). RECK expression in osteosarcoma: Correlation with matrix metalloproteinases activation and tumor invasiveness. Journal of Orthopaedic Research, 25, 696-702. (Pubitemid 46730522)
55. Rao, A. R.,Motiwala, H. G.,& Karim, O. M. (2008). The discovery of prostate-specific antigen. BJU International, 101, 5-10. (Pubitemid 350233553)
56. Lilja, H. (2003). Biology of prostate-specific antigen. Urology, 62, 27-33.
57. Fuchs, E. (1882). Das Sarcom des Uvealtractus. In W. Braumueller (Ed.), Metastasenbildung (pp. 197-206). Vienna: Wilhelm Braumuller.
58. Paget, S. (1889). The distribution of secondary growths in cancer of the breast. Lancet, 1, 571-573.
59. Fidler, I. J. (2003). The pathogenesis of cancer metastasis: The 'seed and soil' hypothesis revisited. Nature Reviews. Cancer, 3, 453-458.
60. Ruoslahti, E., & Rajotte, D. (2000). An address system in the vasculature of normal tissues and tumors. Annual Review of Immunology, 18, 813-827. (Pubitemid 30365398)
61. Brown, D. M., & Metadherin, R. E. (2004). A cell surface protein in breast tumors thatmediates lungmetastasis. Cancer Cell, 5, 365-374. (Pubitemid 38482072)
62. Muller, A., Homey, B., Soto, H., Ge, N., Catron, D., Buchanan, M. E., McClanahan, T., Murphy, E., Yuan, W., Wagner, S. N., Barrera, J. L., Mohar, A., Verástegui, E., & Zlotnik, A. (2001). Involvement of chemokine receptors in breast cancer metastasis. Nature, 410, 50-56. (Pubitemid 32225831)
63. Harbeck, B., Hüttelmaier, S., Schluter, K., Jockusch, B. M., & Illenberger, S. (2000). Phosphorylation of the vasodilatorstimulated phosphoprotein regulates its interaction with actin. The Journal of Biological Chemistry, 275, 30817-30825.
64. McDougall, S. R., Anderson, A. R., & Chaplain, M. A. (2006). Mathematical modelling of dynamic adaptive tumour-induced angiogenesis: Clinical implications and therapeutic targeting strategies. Journal of Theoretical Biology, 241, 564-589. (Pubitemid 44041121)
65. Bergers, G., & Benjamin, L. E. (2003). Tumorigenesis and the angiogenic switch. Nature Reviews. Cancer, 3, 401-410. (Pubitemid 37328844)
66. Kalluri, R. (2003). Basement membranes: Structure, assembly and role in tumour angiogenesis. Nature Reviews. Cancer, 3, 422-433.
67. Thurston, G. (2003). Role of Angiopoietins and Tie receptor tyrosine kinases in angiogenesis and lymphangiogenesis. Cell and Tissue Research, 314, 61-68.
68. Smith, T. G., Robbins, P. A., & Ratcliffe, P. J. (2008). The human side of hypoxia-inducible factor. British Journal of Haematology, 141, 325-334. (Pubitemid 351521147)
69. Harris, A. L. (2002). Hypoxia-a key regulatory factor in tumour growth. Nature Reviews. Cancer, 2, 38-47.
70. Sullivan, R., & Graham, C. H. (2007). Hypoxia-driven selection of the metastatic phenotype. Cancer and Metastasis Reviews, 26, 319-331. (Pubitemid 47101665)
71. Semenza, G. L. (2003). Targeting HIF-1 for cancer therapy. Nature Reviews. Cancer, 3, 721-732.
72. Semenza, G. L. (2007). Evaluation of HIF-1 inhibitors as anticancer agents. Drug Discovery Today, 12, 853-859.
73. Melillo, G. (2006). Inhibiting hypoxia-inducible factor 1 for cancer therapy. Molecular Cancer Research, 4, 601-605.
74. Steeg, P. S. (2006). Tumor metastasis: Mechanistic insights and clinical challenges. Nature Medicine, 12, 895-904.
75. Khan, N., & Mukhtar, H. (2007). Tea polyphenols for health promotion. Life Sciences, 81, 519-533. (Pubitemid 47212236)
76. Chacko, S. M., Thambi, P. T., Kuttan, R., & Nishigaki, I. (2010). Beneficial effects of green tea: Aliterature review. ChineseMedicine, 5, 13.
77. Cao, Y., Cao, R., & Brakenhielm, E. (2002). Antiangiogenic mechanisms of diet-derived polyphenols. The Journal of Nutritional Biochemistry, 13, 380-390. (Pubitemid 34733007)
78. Khan, N., Afaq, F., Saleem, M., Ahmad, N., & Mukhtar, H. (2006). Targeting multiple signaling pathways by green tea polyphenol (-)-epigallocatechin-3-gallate. Cancer Research, 66, 2500-2505.
79. Kaufmann, R., Henklein, P., Henklein, P., & Settmacher, U. (2009). Green tea polyphenol epigallocatechin-3-gallate inhibits thrombin-induced hepatocellular carcinoma cell invasion and p42/p44-MAPKinase activation. Oncology Reports, 21, 1261-1267.
80. Lu, L., Liu, H. M., & Tang, W. X. (2007). Effect of epigallocatechin-3-gallate on the invasiveness of hepatocarcinoma cells in vitro. Zhonghua Gan Zang Bing Za Zhi, 15, 825-827.
81. Lee, S. J., Lee, K. W., Hur, H. J., Chun, J. Y., Kim, S. Y., & Lee, H. J. (2007). Phenolic phytochemicals derived from red pine (Pinus densiflora) inhibit the invasion and migration of SKHep-1 human hepatocellular carcinoma cells. Annals of the New York Academy of Sciences, 1095, 536-544.
82. Zhen, M. C., Huang, X. H., Wang, Q., Sun, K., Liu, Y. J., Li, W., Zhang, L. J., Cao, L. Q., & Chen, X. L. (2006). Green tea polyphenol epigallocatechin-3-gallate suppresses rat hepatic stellate cell invasion by inhibition of MMP-2 expression and its activation. Acta Pharmacologica Sinica, 27, 1600-1607. (Pubitemid 44813898)
83. Zhang, G., Miura, Y., & Yagasaki, K. (2000). Suppression of adhesion and invasion of hepatoma cells in culture by tea compounds through antioxidative activity. Cancer Letters, 159, 169-173.
84. Zhang, G., Miura, Y., & Yagasaki, K. (2001). Inhibition of hepatoma cell invasion beneath mesothelial-cell monolayer by sera from tea- and related component-treated rats and their modes of action. Cytotechnology, 36, 187-193. (Pubitemid 34067727)
85. Yang, J., Wei, D., & Liu, J. (2005). Repressions of MMP-9 expression and NF-kappa B localization are involved in inhibition of lung carcinoma 95-D cell invasion by (-)-epigallocatechin-3-gallate. Biomedicine & Pharmacotherapy, 59, 98-103. (Pubitemid 40424556)
86. Hazgui, S., Bonnomet, A., Nawrocki-Raby, B., Milliot, M., Terryn, C., Cutrona, J., Polette, M., Birembaut, P., & Zahm, J. M. (2008). Epigallocatechin-3-gallate (EGCG) inhibits the migratory behavior of tumor bronchial epithelial cells. Respiratory Research, 9, 33.
87. Belguise, K., Guo, S., & Sonenshein, G. E. (2007). Activation of FOXO3a by the green tea polyphenol epigallocatechin-3-gallate induces estrogen receptor alpha expression reversing invasive phenotype of breast cancer cells. Cancer Research, 67, 5763-5770. (Pubitemid 46985009)
88. Thangapazham, R. L., Passi, N., & Maheshwari, R. K. (2007). Green tea polyphenol and epigallocatechin gallate induce apoptosis and inhibit invasion in human breast cancer cells. Cancer Biology& Therapy, 6, 1938-1943. (Pubitemid 351590407)
89. Sen, T., & Chatterjee, A. (2010). Epigallocatechin-3-gallate (EGCG) downregulates EGF-induced MMP-9 in breast cancer cells: Involvement of integrin receptor α5β1 in the process. European Journal of Nutrition, 50, 465-478.
90. Slivova, V., Zaloga, G., DeMichele, S. J., Mukerji, P., Huang, Y. S., Siddiqui, R., Harvey, K., Valachovicova, T., & Sliva, D. (2005). Green tea polyphenols modulate secretion of urokinase plasminogen activator (uPA) and inhibit invasive behavior of breast cancer cells. Nutrition and Cancer, 52, 66-73. (Pubitemid 41232651)
91. Zhang, Y., Han, G., Fan, B., Zhou, Y., Zhou, X., Wei, L., & Zhang, J. (2009). Green tea (-)-epigallocatechin-3-gallate downregulates VASP expression and inhibits breast cancer cell migration and invasion by attenuating Rac1 activity. European Journal of Pharmacology, 606, 172-179.
92. Sen, T., Moulik, S., Dutta, A., Choudhury, P. R., Banerji, A., Das, S., Roy, M., & Chatterjee, A. (2009). Multifunctional effect of epigallocatechin-3-gallate (EGCG) in downregulation of gelatinase-A (MMP-2) in human breast cancer cell line MCF-7. Life Sciences, 84, 194-204.
93. Kushima, Y., Iida, K., Nagaoka, Y., Kawaratani, Y., Shirahama, T., Sakaguchi, M., Baba, K., Hara, Y., & Uesato, S. (2009). Inhibitory effect of (-)-epigallocatechin and (-)-epigallocatechin gallate against heregulin beta1-induced migration/invasion of the MCF-7 breast carcinoma cell line. Biological & Pharmaceutical Bulletin, 32, 899-904.
94. Farabegoli, F., Papi, A., & Orlandi,M. (2011). (-)Epigallocatechin-3- gallate downregulates EGFR, MMP-2, MMP-9 EMMPRIN and inhibits the invasion ofMCF-7 tamoxifen resistant cells. Biosciences Reports, 31, 99-108.
95. Bigelow, R. L., & Cardelli, J. A. (2006). The green tea catechins, (-)-epigallocatechin-3- gallate (EGCG) and (-)-epicatechin-3-gallate (ECG), inhibit HGF/Met signaling in immortalized and tumorigenic breast epithelial cells. Oncogene, 25, 1922-1930.96.
96. Vayalil, P. K., & Katiyar, S. K. (2004). Treatment of epigallocatechin-3-gallate inhibits matrix metalloproteinases-2 and -9 via inhibition of activation of mitogen-activated protein kinases, c-Jun and NF-kappaB in human prostate carcinoma DU-145 cells. Prostate, 59, 33-42.
97. Siddiqui, I. A.,Malik, A., Adhami, V. M., Asim, M., Hafeez, B. B., Sarfaraz, S., & Mukhtar, H. (2008). Green tea polyphenol EGCG sensitizes human prostate carcinoma LNCaP cells to TRAILmediated apoptosis and synergistically inhibits biomarkers associated with angiogenesis and metastasis. Oncogene, 27, 2055-2063. (Pubitemid 351442738)
98. Pezzato, E., Sartor, L., Dell'Aica, I., Dittadi, R., Gion, M., Belluco, C., Lise, M., & Garbisa, S. (2004). Prostate carcinoma and green tea: PSA-triggered basement membrane degradation and MMP-2 activation are inhibited by (-) epigallocatechin-3-gallate. International Journal of Cancer, 112, 787-792. (Pubitemid 39435263)
99. Sartor, L., Pezzato, E., Donà, M., Dell'Aica, I., Calabrese, F., Morini, M., Albini, A., & Garbisa, S. (2004). Prostate carcinoma and green tea: (-)epigallocatechin-3-gallate inhibits inflammationtriggered MMP-2 activation and invasion in murine TRAMP model. International Journal of Cancer, 112, 823-829. (Pubitemid 39435267)
100. Larsen, C. A., & Dashwood, R. H. (2010). (-)-Epigallocatechin-3- gallate inhibits Met signaling, proliferation, and invasiveness in human colon cancer cells. Archives of Biochemistry and Biophysics, 501, 52-57.
101. Ogasawara, M., Matsunaga, T., & Suzuki, H. (2007). Differential effects of antioxidants on the in vitro invasion, growth and lung metastasis of murine colon cancer cells. Biological & Pharmaceutical Bulletin, 30, 200-204. (Pubitemid 46066348)
102. Lim, Y. C., Park, H. Y., Hwang, H. S., Kang, S. U., Pyun, J. H., Lee, M. H., Choi, E. C., & Kim, C. H. (2008). (-)-Epigallocatechin-3-gallate (EGCG) inhibits HGF-induced invasion and metastasis in hypopharyngeal carcinoma cells. Cancer Letters, 271, 140-152.
103. Hsu, S. D., Singh, B. B., Lewis, J. B., Borke, J. L., Dickinson, D. P., Drake, L., Caughman, G. B., & Schuster, G. S. (2002). Chemoprevention of oral cancer by green tea. General Dentistry, 50, 140-146.
104. Ho, Y. C., Yang, S. F., Peng, C. Y., Chou, M. Y., & Chang, Y. C. (2007). Epigallocatechin-3-gallate inhibits the invasion of human oral cancer cells and decreases the productions of matrix metalloproteinases and urokinase-plasminogen activator. Journal of Oral Pathology & Medicine, 36, 588-593.
105. Kato, K., Long, N. K., Makita, H., Toida, M., Yamashita, T., Hatakeyama, D., Hara, A., Mori, H., & Shibata, T. (2008). Effects of green tea polyphenol on methylation status of RECK gene and cancer cell invasion in oral squamous cell carcinoma cells. British Journal of Cancer, 99, 647-654.
106. Park, J. H., Yoon, J. H., Kim, S. A., Ahn, S. G., & Yoon, J. H. (2010). (-)-Epigallocatechin-3-gallate inhibits invasion and migration of salivary gland adenocarcinoma cells. Oncology Reports, 23, 585-590.
107. Kim, H. S., Kim, M. H., Jeong, M., Hwang, Y. S., Lim, S. H., Shin, B. A., Ahn, B. W., & Jung, Y. D. (2004). EGCG blocks tumor promoter-induced MMP-9 expression via suppression of MAPK and AP-1 activation in human gastric AGS cells. Anticancer Research, 24, 747-753. (Pubitemid 38625017)
108. Maeda-Yamamoto, M., Kawahara, H., Tahara, N., Tsuji, K., Hara, Y., & Isemura, M. (1999). Effects of tea polyphenols on the invasion and matrix metalloproteinases activities of human fibrosarcoma HT1080 cells. Journal of Agricultural and Food Chemistry, 47, 2350-2354. (Pubitemid 29325123)
109. Maeda-Yamamoto, M., Suzuki, N., Sawai, Y., Miyase, T., Sano, M., Hashimoto-Ohta, A., & Isemura, M. (2003). Association of suppression of extracellular signal-regulated kinase phosphorylation by epigallocatechin gallate with the reduction of matrix metalloproteinase activities in human fibrosarcoma HT1080 cells. Journal of Agricultural and Food Chemistry, 51, 1858-1863.
110. Garbisa, S., Sartor, L., Biggin, S., Salvato, B., Benelli, R., & Albini, A. (2001). Tumor gelatinases and invasion inhibited by the green tea flavanol epigallocatechin-3-gallate. Cancer, 91, 822-832. (Pubitemid 32173309)
111. Dell'Aica, I., Donà, M., Sartor, L., Pezzato, E., & Garbisa, S. (2002). (-) Epigallocatechin-3-gallate directly inhibits MT1-MMP activity, leading to accumulation of nonactivated MMP-2 at the cell surface. Laboratory Investigation, 82, 1685-1693. (Pubitemid 35462981)
112. Takada, M., Nakamura, Y., Koizumi, T., Toyama, H., Kamigaki, T., Suzuki, Y., Takeyama, Y., & Kuroda, Y. (2002). Suppression of human pancreatic carcinoma cell growth and invasion by epigallocatechin-3-gallate. Pancreas, 25, 45-48. (Pubitemid 34760835)
113. Pilorget, A., Berthet, V., Luis, J., Moghrabi, A., Annabi, B., & Béliveau, R. (2003). Medulloblastoma cell invasion is inhibited by green tea (-)epigallocatechin-3-gallate. Journal of Cellular Biochemistry, 90, 745-755. (Pubitemid 37392465)
114. Takada, M., Ku, Y., Habara, K., Ajiki, T., Suzuki, Y., & Kuroda, Y. (2002). Inhibitory effect of epigallocatechin-3-gallate on growth and invasion in human biliary tract carcinoma cells. World Journal of Surgery, 26, 683-686. (Pubitemid 36920343)
115. Fassina, G., Venè, R., Morini, M., Minghelli, S., Benelli, R., Noonan, D. M., & Albini, A. (2004). Mechanisms of inhibition of tumor angiogenesis and vascular tumor growth by epigallocatechin-3-gallate. Clinical Cancer Research, 10, 4865-4873. (Pubitemid 38955541)
116. Liu, J. D., Chen, S. H., Lin, C. L., Tsai, S. H., & Liang, Y. C. (2001). Inhibition of melanoma growth and metastasis by combination with (-)-epigallocatechin-3-gallate and dacarbazine in mice. Journal of Cellular Biochemistry, 83, 631-642.
117. Suzuki, Y., & Isemura, M. (2001). Inhibitory effect of epigallocatechin gallate on adhesion of murine melanoma cells to laminin. Cancer Letters, 173, 15-20. (Pubitemid 32907504)
118. Wu, Y., Lin, Y., Liu, H., & Li, J. (2008). Inhibition of invasion and up-regulation of E-cadherin expression in human malignant melanoma cell line A375 by (-)-epigallocatechin-3-gallate. Journal of Huazhong University of Science and Technology. Medical Sciences, 28, 356-359.
119. Kwak, I., Shin, Y. H., Kim, M., Cha, H. Y., Nam, H. J., Lee, B. S., Chaudhary, S. C., Pai, K. S., & Lee, J. H. (2011). Epigallocatechin-3- gallate inhibits paracrine and autocrine hepatocyte growth factor/scatter factor-induced tumor cell migration and invasion. Experimental & Molecular Medicine, 43, 111-120.
120. Messina, M., Nagata, C., & Wu, A. H. (2006). Estimated Asian adult soy protein and isoflavone intakes. Nutrition and Cancer, 55, 1-12. (Pubitemid 44477039)
121. Bobe, G., Sansbury, L. B., Albert, P. S., Cross, A. J., Kahle, L., Ashby, J., Slattery, M. L., Caan, B., Paskett, E., Iber, F., Kikendall, J.W., Lance, P., Daston, C.,Marshall, J. R., Schatzkin, A.,&Lanza, E. (2008). Dietary flavonoids and colorectal adenoma recurrence in the polyp prevention trial. Cancer Epidemiology, Biomarkers & Prevention, 17, 1344-1353.
122. Hwang, Y. W., Kim, S. Y., Jee, S. H., Kim, Y. N., & Nam, C. M. (2009). Soy food consumption and risk of prostate cancer: A meta-analysis of observational studies. Nutrition and Cancer, 61, 598-606.
123. Magee, P. J., & Rowland, I. R. (2004). Phyto-oestrogens, their mechanism of action: Current evidence for a role in breast and prostate cancer. British Journal of Nutrition, 91, 513-531. (Pubitemid 38584776)
124. Park, O. J., & Surh, Y. J. (2004). Chemopreventive potential of epigallocatechin gallate and genistein: Evidence from epidemiological and laboratory studies. Toxicology Letters, 150, 43-56. (Pubitemid 38447236)
125. Sarkar, F. H., & Li, Y. (2002). Mechanisms of cancer chemoprevention by soy isoflavone genistein. Cancer and Metastasis Reviews, 21, 265-280. (Pubitemid 36071914)
126. Sarkar, F. H., & Li, Y. (2003). Soy isoflavones and cancer prevention. Cancer Investigation, 217, 44-757.
127. Gu, Y., Zhu, C. F., Iwamoto, H., & Chen, J. S. (2005). Genistein inhibits invasive potential of human hepatocellular carcinoma byaltering cell cycle, apoptosis, and angiogenesis. World Journal of Gastroenterology, 11, 6512-6517. (Pubitemid 43136890)
128. Valachovicova, T., Slivova, V., Bergman, H., Shuherk, J., & Sliva, D. (2004). Soy isoflavones suppress invasiveness of breast cancer cells by the inhibition of NF-kappaB/AP-1-dependent and -independent pathways. International Journal of Oncology, 25, 1389-1395.
129. Magee, P. J., McGlynn, H., & Rowland, I. R. (2004). Differential effects of isoflavones and lignans on invasiveness of MDA-MB-231 breast cancer cells in vitro. Cancer Letters, 208, 35-41. (Pubitemid 38501781)
130. Kousidou, O. C., Mitropoulou, T. N., Roussidis, A. E., Kletsas, D., Theocharis, A. D., & Karamanos, N. K. (2005). Genistein suppresses the invasive potential of human breast cancer cells through transcriptional regulation of metalloproteinases and their tissue inhibitors. International Journal of Oncology, 26, 1101-1109.
131. Hsu, E. L., Chen, N. A., Westbrook, F., Wang, R., Zhang, R., Taylor, T., & Hankinson, O. (2009). Modulation of CXCR4, CXCL12, and tumor cell invasion potential in vitro by phytochemicals. Journal of Oncology, 2009, 491985.
132. Shao, Z. M., Wu, J., Shen, Z. Z., & Barsky, S. H. (1998). Genistein inhibits both constitutive and EGF-stimulated invasion in ER-negative human breast carcinoma cell lines. Anticancer Research, 18, 1435-1439. (Pubitemid 28342542)
133. Scholar, E. M., & Toews, M. L. (1994). Inhibition of invasion of murine mammary carcinoma cells by the tyrosine kinase inhibitor genistein. Cancer Letters, 87, 159-162.
134. Farina, H. G., Pomies, M., Alonso, D. F., & Gomez, D. E. (2006). Antitumor and antiangiogenic activity of soy isoflavone genistein in mouse models of melanoma and breast cancer. Oncology Reports, 16, 885-891.
135. Zhang, L. L., Li, L., Wu, D. P., Fan, J. H., Li, X., Wu, K. J., Wang, X. Y., & He, D. L. (2008). A novel anti-cancer effect of genistein: Reversal of epithelial mesenchymal transition in prostate cancer cells. Acta Pharmacologica Sinica, 29, 1060-1068.
136. Li, Y., Kucuk, O., Hussain, M., Abrams, J., Cher, M. L., & Sarkar, F. H. (2006). Antitumor and antimetastatic activities of docetaxel are enhanced by genistein through regulation of osteoprotegerin/receptor activator of nuclear factor-kappaB (RANK)/RANK ligand/MMP-9 signaling in prostate cancer. Cancer Research, 66, 4816-4825.
137. El Touny, L. H., & Banerjee, P. P. (2009). Identification of a biphasic role for genistein in the regulation of prostate cancer growth and metastasis. Cancer Research, 69, 3695-3703.
138. Huang, X., Chen, S., Xu, L., Liu, Y., Deb, D. K., Platanias, L. C., & Bergan, R. C. (2005). Genistein inhibits p38 map kinase activation, matrix metalloproteinase type 2, and cell invasion in human prostate epithelial cells. Cancer Research, 65, 3470-3478. (Pubitemid 40524634)
139. Xu, L., & Bergan, R. C. (2006). Genistein inhibits matrix metalloproteinase type 2 activation and prostate cancer cell invasion by blocking the transforming growth factor beta-mediated activation of mitogen-activated protein kinase-activated protein kinase 2-27-kDa heat shock protein pathway. Molecular Pharmacology, 70, 869-877. (Pubitemid 44268444)
140. Xu, L., Ding, Y., Catalona, W. J., Yang, X. J., Anderson, W. F., Jovanovic, B., Wellman, K., Killmer, J., Huang, X., Scheidt, K. A., Montgomery, R. B., & Bergan, R. C. (2009). MEK4 function, genistein treatment, and invasion of human prostate cancer cells. Journal of the National Cancer
141. El Touny, L. H., & Banerjee, P. P. (2007). Genistein induces the metastasis suppressor kangai-1 which mediates its anti-invasive effects in TRAMP cancer cells. Biochemical and Biophysics Research Communications, 361, 169-175. (Pubitemid 47103319)
142. Yan, C., & Han, R. (1999). Protein tyrosine kinase inhibitor genistein suppresses in vitro invasion of HT1080 human fibrosarcoma cells. Zhonghua Zhong Liu Za Zhi, 21, 171-174. (Pubitemid 29291282)
143. Yan, C., & Han, R. (1999). Effects of genistein on invasion and matrix metalloproteinase activities of HT1080 human fibrosarcoma cells. Chinese Medical Sciences Journal, 14, 129-133.
144. Hölting, T., Siperstein, A. E., Clark, O. H., & Duh, Q. Y. (1995). Epidermal growth factor (EGF)- and transforming growth factor alpha-stimulated invasion and growth of follicular thyroid cancer cells can be blocked by antagonism to the EGF receptor and tyrosine kinase in vitro. European Journal of Endocrinology, 132, 229-235.
145. Yan, C., & Han, R. (1998). Genistein suppresses adhesioninduced protein tyrosine phosphorylation and invasion of B16-BL6 melanoma cells. Cancer Letters, 129, 117-124. (Pubitemid 28375246)
146. Singh, R. P.,&Agarwal, R. (2002). Flavonoid antioxidant silymarin and skin cancer. Antioxidants & Redox Signaling, 4, 655-663. (Pubitemid 35001450)
147. Chu, S. C., Chiou, H. L., Chen, P. N., Yang, S. F., & Hsieh, Y. S. (2004). Silibinin inhibits the invasion of human lung cancer cells via decreased productions of urokinase-plasminogen activator and matrix metalloproteinase-2. Molecular Carcinogenesis, 40, 143-149.
148. Chen, P. N., Hsieh, Y. S., Chiou, H. L., & Chu, S. C. (2005). Silibinin inhibits cell invasion through inactivation of both PI3K-Akt and MAPK signaling pathways. Chemico-Biological Interactions, 156, 141-150.
149. Lee, S. O., Jeong, Y. J., Im, H. G., Kim, C. H., Chang, Y. C., & Lee, I. S. (2007). Silibinin suppresses PMA-induced MMP-9 expression by blocking the AP-1 activation via MAPK signaling pathways in MCF-7 human breast carcinoma cells. Biochemical and Biophysics Research Communications, 354, 165-171. (Pubitemid 46123215)
150. Kim, S., Choi, J. H., Lim, H. I., Lee, S. K., Kim, W. W., Kim, J. S., Kim, J. H., Choe, J. H., Yang, J. H., Nam, S. J., & Lee, J. E. (2009). Silibinin prevents TPA-induced MMP-9 expression and VEGF secretion by inactivation of the Raf/MEK/ERK pathway in MCF-7 human breast cancer cells. Phytomedicine, 16, 573-580.
151. Mokhtari, M. J., Motamed, N., & Shokrgozar, M. A. (2008). Evaluation of silibinin on the viability, migration and adhesion of the human prostate adenocarcinoma (PC-3) cell line. Cell Biology International, 32, 888-892.
152. Wu, K. J., Zeng, J., Zhu, G. D., Zhang, L. L., Zhang, D., Li, L., Fan, J. H., Wang, X. Y., & He, D. L. (2009). Silibinin inhibits prostate cancer invasion, motility and migration by suppressing vimentin and MMP-2 expression. Acta Pharmacologica Sinica, 30, 1162-1168.
153. Wu, K., Zeng, J., Li, L., Fan, J., Zhang, D., Xue, Y., Zhu, G., Yang, L., Wang, X., & He, D. (2010). Silibinin reverses epithelial-to-mesenchymal transition in metastatic prostate cancer cells by targeting transcription factors. Oncology Reports, 23, 1545-1552.
154. Chen, P. N., Hsieh, Y. S., Chiang, C. L., Chiou, H. L., Yang, S. F., & Chu, S. C. (2006). Silibinin inhibits invasion of oral cancer cells by suppressing the MAPK pathway. Journal of Dental Research, 85, 220-225.
155. Chang, H. R., Chen, P. N., Yang, S. F., Sun, Y. S., Wu, S. W., Hung, T. W., Lian, J. D., Chu, S. C., & Hsieh, Y. S. (2011). Silibinin inhibits the invasion and migration of renal carcinoma 786-O cells in vitro, inhibits the growth of xenografts in vivo and enhances chemosensitivity to 5-fluorouracil and paclitaxel. Molecular Carcinogenesis, 50, 811-823.
156. Hsieh, Y. S., Chu, S. C., Yang, S. F., Chen, P. N., Liu, Y. C., & Lu, K. H. (2007). Silibinin suppresses human osteosarcoma MG-63 cell invasion by inhibiting the ERK-dependent c-Jun/AP-1 induction of MMP-2. Carcinogenesis, 28, 977-987.
157. Naderi,G.A.,Asgary, S., Sarraf-Zadegan,N.,&Shirvany,H. (2003). Anti-oxidant effect of flavonoids on the susceptibility of LDL oxidation. Molecular and Cellular Biochemistry, 246, 193-196. (Pubitemid 36798741)
158. Mamani-Matsuda, M. (2006). Therapeutic and preventive properties of quercetin in experimental arthritis correlate withdecreased macrophage inflammatory mediators. Biochemical Pharmacology, 72, 1304-1310.
159. Lotito, S. B., & Frei, B. (2006). Dietary flavonoids attenuate tumor necrosis factor alpha-induced adhesion molecule expression in human aortic endothelial cells. Structure-function relationships and activity after first pass metabolism. The Journal of Biological Chemistry, 281, 37102-37110. (Pubitemid 46042180)
160. Lin, C.W., Hou,W. C., Shen, S. C., Juan, S. H., Ko, C. H.,Wang, L. M., & Chen, Y. C. (2008). Quercetin inhibition of tumor invasion via suppressing PKC delta/ERK/AP-1-dependent matrix metalloproteinase-9 activation in breast carcinoma cells. Carcinogenesis, 29, 1807-1815.
161. Phromnoi, K., Yodkeeree, S., Anuchapreeda, S., & Limtrakul, P. (2009). Inhibition of MMP-3 activity and invasion of the MDAMB- 231 human invasive breast carcinoma cell line by bioflavonoids. Acta Pharmacologica Sinica, 30, 1169-1176.
162. Vijayababu, M. R., Arunkumar, A., Kanagaraj, P., Venkataraman, P., Krishnamoorthy, G., & Arunakaran, J. (2006). Quercetin downregulates matrix metalloproteinases 2 and 9 proteins expression in prostate cancer cells (PC-3). Molecular and Cellular Biochemistry, 287, 109-116. (Pubitemid 44057398)
163. Senthilkumar, K., Arunkumar, R., Elumalai, P., Sharmila, G., Gunadharini, D. N., Banudevi, S., Krishnamoorthy, G., Benson, C. S., & Arunakaran, J. (2011). Quercetin inhibits invasion, migration and signalling molecules involved in cell survival and proliferation of prostate cancer cell line (PC-3). Cell Biochemistry and Function, 29, 87-95.
164. Labbé, D., Provençal, M., Lamy, S., Boivin, D., Gingras, D., & Béliveau, R. (2009). The flavonols quercetin, kaempferol, and myricetin inhibit hepatocyte growth factor-induced medulloblastoma cell migration. The Journal of Nutrition, 139, 646-652.
165. Chiu, W. T., Shen, S. C., Chow, J. M., Lin, C. W., Shia, L. T., & Chen, Y. C. (2010). Contribution of reactive oxygen species to migration/invasion of human glioblastoma cells U87 via ERKdependent COX-2/PGE(2) activation. Neurobiology of Disease, 37, 118-129.
166. Zhang, F. L., Zhang, W., Chen, X. M., & Luo, R. Y. (2008). Effects of quercetin and quercetin in combination with cisplatin on adhesion, migration and invasion of HeLa cells. Zhonghua Fu Chan Ke Za Zhi, 43, 619-621.
167. Zhang, W., & Zhang, F. (2009). Effects of quercetin on proliferation, apoptosis, adhesion and migration, and invasion of HeLa cells. European Journal of Gynaecological Oncology, 30, 60-64.
168. Lin, Y. S., Tsai, P. H., Kandaswami, C. C., Cheng, C. H., Ke, F. C., Lee, P. P., Hwang, J. J., & Lee, M. T. (2011). Effects of dietary flavonoids, luteolin and quercetin on the reversal of epithelial-mesenchymal transition in A431 epidermal cancer cells. Cancer Science, 102, 1829-1839.
169. Caltagirone, S., Rossi, C., Poggi, A., Ranelletti, F. O., Natali, P. G., Brunetti, M., Aiello, F. B., & Piantelli, M. (2000). Flavonoids apigenin and quercetin inhibit melanoma growth and metastatic potential. International Journal of Cancer, 87, 595-600. (Pubitemid 30639822)
170. Zhang, X. M., Huang, S. P., & Xu, Q. (2004). Quercetin inhibits the invasion of murine melanoma B16-BL6 cells by decreasing pro-MMP-9 via the PKC pathway. Cancer Chemotherapy and Pharmacology, 53, 82-88.
171. Jeong, Y., Tyner, A. L., & Park, J. H. (2007). Induction of cell cycle arrest and apoptosis in HT-29 human colon cancer cells by the dietary compound luteolin. American Journal of Physiology. Gastrointestinal and Liver Physiology, 292, G66-G75. (Pubitemid 46090252)
172. Selvendiran, K., Koga, H., Ueno, T., Yoshida, T., Maeyama, M., Torimura, T., Yano, H., Kojiro, M., & Sata, M. (2006). Luteolin promotes degradation in signal transducer and activator of transcription 3 in human hepatoma cells: An implication for the antitumor potential of flavonoids. Cancer Research, 66, 4826-4834.
173. Lee, W. J., Wu, L. F., Chen, W. K., Wang, C. J., & Tseng, T. H. (2006). Inhibitory effect of luteolin on hepatocyte growth factor/scatter factor-induced HepG2 cell invasion involving both MAPK/ERKs and PI3K-Akt pathways. Chemico-Biological Interactions, 160, 123-133.
174. Attoub, S., Hassan, A. H., Vanhoecke, B., Iratni, R., Takahashi, T., Gaben, A. M., Bracke, M., Awad, S., John, A., Kamalboor, H. A., Al Sultan, M. A., Arafat, K., Gespach, C., & Petroianu, G. (2011). Inhibition of cell survival, invasion, tumor growth and histone deacetylase activity by the dietary flavonoid luteolin in human epithelioid cancer cells. European Journal of Pharmacology, 651, 18-25.
175. Lansky, E. P., Harrison, G., Froom, P., & Jiang, W. G. (2005). Pomegranate (Punica granatum) pure chemicals show possible synergistic inhibition of human PC-3 prostate cancer cell invasion across Matrigel. Investigational New Drugs, 23, 121-122. (Pubitemid 40386228)
176. Zhou, Q., Yan, B., Hu, X., Li, X. B., Zhang, J., & Fang, J. (2009). Luteolin inhibits invasion of prostate cancer PC3 cells through Ecadherin. Molecular Cancer Therapeutics, 8, 1684-1691.
177. Lin, C. W., Shen, S. C., Chien, C. C., Yang, L. Y., Shia, L. T., & Chen, Y. C. (2010). 12-O-tetradecanoylphorbol-13-acetate-induced invasion/migration of glioblastoma cells through activating PKC alpha/ERK/NF-kappaB-dependent MMP-9 expression. Journal of Cellular Physiology, 225, 472-481.
178. Ross, J. A., & Kasum, C. M. (2002). Dietary flavonoids: Bioavailability, metabolic effects, and safety. Annual Review of Nutrition, 22, 19-34. (Pubitemid 35221452)
179. Gupta, S., Afaq, F., & Mukhtar, H. (2001). Selective growthinhibitory, cell-cycle deregulatory and apoptotic response of apigenin in normal versus human prostate carcinoma cells. Biochemical and Biophysics Research Communications, 287, 914-920. (Pubitemid 32953563)
180. Wang,W., Heideman, L., Chung, C. S., Pelling, J. C., Koehler, K. J., & Birt, D. F. (2000). Cell-cycle arrest at G2/M and growth inhibition by apigenin in human colon carcinoma cell lines. Molecular Carcinogenesis, 28, 102-110. (Pubitemid 30432478)
181. Way, T. D., Kao, M. C., & Lin, J. K. (2004). Apigenin induces apoptosis through proteasomal degradation of HER2/neu in HER2/neu-overexpressing breast cancer cells via the phosphatidylinositol 3-kinase/Akt-dependent pathway. The Journal of Biological Chemistry, 279, 4479-4489.
182. Zheng, P. W., Chiang, L. C., & Lin, C. C. (2005). Apigenin induced apoptosis through p53-dependent pathway in human cervical carcinoma cells. Life Sciences, 76, 1367-1379.
183. Czyz, J., Madeja, Z., Irmer, U., Korohoda, W., & Hülser, D. F. (2005). Flavonoid apigenin inhibits motility and invasiveness of carcinoma cells in vitro. International Journal of Cancer, 114, 12-18. (Pubitemid 40194304)
184. Lindenmeyer, F., Li, H., Menashi, S., Soria, C., & Lu, H. (2001). Apigenin acts on the tumor cell invasion process and regulates protease production. Nutrition and Cancer, 39, 139-147. (Pubitemid 32880959)
185. Lee, W. J., Chen, W. K., Wang, C. J., Lin, W. L., & Tseng, T. H. (2008). Apigenin inhibits HGF-promoted invasive growth and metastasis involving blocking PI3K/Akt pathway and beta 4 integrin function in MDA-MB-231 breast cancer cells. Toxicology and Applied Pharmacology, 226, 178-191.
186. Franzen, C. A., Amargo, E., Todorović, V., Desai, B. V., Huda, S., Mirzoeva, S., Chiu, K., Grzybowski, B. A., Chew, T. L., Green, K. J., & Pelling, J. C. (2009). The chemopreventive bioflavonoid apigenin inhibits prostate cancer cell motility through the focal adhesion kinase/Src signalingmechanism. Cancer Prevention Research (Phila), 2, 830-841.
187. Zhu, F., Liu, X. G., & Liang, N. C. (2003). Effect of emodin and apigenin on invasion of human ovarian carcinoma HO-8910 PM cells in vitro. Ai Zheng, 22, 358-362.
188. Hu, X. W., Meng, D., & Fang, J. (2008). Apigenin inhibited migration and invasion of human ovarian cancer A2780 cells through focal adhesion kinase. Carcinogenesis, 29, 2369-2376.
189. Noh, H. J., Sung, E. G., Kim, J. Y., Lee, T. J., & Song, I. H. (2010). Suppression of phorbol-12-myristate-13-acetate-induced tumor cell invasion by apigenin via the inhibition of p38 mitogenactivated protein kinase-dependent matrix metalloproteinase-9 expression. Oncology Reports, 24, 277-283.
190. Maggiolini, M., Recchia, A. G., Bonofiglio, D., Catalano, S., Vivacqua, A., Carpino, A., Rago, V., Rossi, R., & Andò, S. (2005). The red wine phenolics piceatannol and myricetin act as agonists for estrogen receptor in human breast cancer cells. Journal of Molecular Endocrinology, 35, 269-281. (Pubitemid 41556175)
191. Nöthlings, U., Murphy, S. P.,Wilkens, L. R., Henderson, B. E., & Kolonel, L. N. (2007). Flavonols and pancreatic cancer risk: The multiethnic cohort study. American Journal of Epidemiology, 166, 924-931. (Pubitemid 47511689)
192. Shih, Y. W., Wu, P. F., Lee, Y. C., Shi, M. D., & Chiang, T. A. (2009). Myricetin suppresses invasion and migration of human lung adenocarcinoma A549 cells: Possible mediation by blocking the ERK signaling pathway. Journal of Agricultural and Food Chemistry, 57, 3490-3499.
193. Ko, C. H., Shen, S. C., Lee, T. J., & Chen, Y. C. (2005). Myricetin inhibits matrix metalloproteinase 2 protein expression and enzyme activity in colorectal carcinoma cells. Molecular Cancer Therapeutics, 4, 281-290. (Pubitemid 40340207)
194. Kawaii, S., Tomono, Y., Katase, E., Ogawa, K.,& Yano, M. (1999). Antiproliferative activity of flavonoids on several cancer cell lines. Bioscience, Biotechnology, and Biochemistry, 63, 896-899. (Pubitemid 129562768)
195. Bracke, M., Vyncke, B., Opdenakker, G., Foidart, J. M., de Pestel, G., & Mareel, M. (1991). Effects of catechins and citrus flavonoids on invasion in vitro. Clinical & Experimental Metastasis, 9, 13-25.
196. Mareel, M. M., & De Mets, M. (1989). Anti-invasive activities of experimental chemotherapeutic agents. Critical Reviews in Oncology/Haematology, 9, 263-303.
197. Brack, M. E., Boterberg, T., Depypere, H. T., Stove, C., Leclercq, G., & Mareel, M. M. (2002). The citrus methoxyflavone tangeretin affects human cell-cell interactions. Advances in Experimental Medicine and Biology, 505, 135-139. (Pubitemid 34526430)
198. Rooprai, H. K., Kandanearatchi, A., Maidment, S. L., Christidou, M., Trillo-Pazos, G., Dexter, D. T., Rucklidge, G. J., Widmer, W., & Pilkington, G. J. (2001). Evaluation of the effects of swainsonine, captopril, tangeretin and nobiletin on the biological behaviour of brain tumour cells in vitro. Neuropathology and Applied Neurobiology, 27, 29-39. (Pubitemid 32291186)
199. Martínez Conesa, C., Vicente Ortega, V., Yáñez Gascón, M. J., Alcaraz Baños, M., Canteras Jordana, M., Benavente-García, O., & Castillo, J. (2005). Treatment of metastatic melanoma B16F10 by the flavonoids tangeretin, rutin, and diosmin. Journal of Agricultural and Food Chemistry, 53, 6791-6797.
200. Park, J. S., Rho, H. S., Kim, D. H., & Chang, I. S. (2006). Enzymatic preparation of kaempferol from green tea seed and its antioxidant activity. Journal of Agricultural and Food Chemistry, 54, 2951-2956.
201. Calderon-Montaño, J. M., Burgos-Moron, E., Perez-Guerrero, C., & Lopez-Lazaro, M. (2011). A review on the dietary flavonoid kaempferol. Mini Reviews in Medicinal Chemistry, 11, 298-344.
202. Shen, S. C., Lin, C. W., Lee, H. M., Chien, L. L., & Chen, Y. C. (2006). Lipopolysaccharide plus 12-o-tetradecanoylphorbol 13- acetate induction of migration and invasion of glioma cells in vitro and in vivo: Differential inhibitory effects of flavonoids. Neuroscience, 140, 477-489.
203. Lee, E. J., Kim, S. Y., Hyun, J. W., Min, S. W., Kim, D. H., & Kim, H. S. (2010). Glycitein inhibits glioma cell invasion through down-regulation ofMMP-3 andMMP-9 gene expression. Chemico- Biological Interactions, 185, 18-24.
204. Park, S. Y., Lim, S. S., Kim, J. K., Kang, I. J., Kim, J. S., Lee, C., Kim, J., & Park, J. H. (2010). Hexane-ethanol extract of Glycyrrhiza uralensis containing licoricidin inhibits the metastatic capacity of DU145 human prostate cancer cells. British Journal of Nutrition, 104, 1-11.
205. Kahkonen, M. P., & Heinonen, M. (2003). Antioxidant activity of anthocyanins and their aglycons. Journal of Agricultural and Food Chemistry, 51, 628-633.
206. Jang, M., Cai, L., Udeani, G. O., Slowing, K. V., Thomas, C. F., Beecher, C. W., Fong, H. H., Farnsworth, N. R., Kinghorn, A. D., Mehta, R. G., Moon, R. C., & Pezzuto, J. M. (1997). Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science, 275, 218-220. (Pubitemid 127696281)
207. Middleton, E., Jr., Kandaswami, C., & Theoharides, T. C. (2000). The effects of plant flavonoids on mammalian cells: Implications for inflammation, heart disease, and cancer. Pharmacological Reviews, 52, 673-751.
208. Katsube, N., Iwashita, K., Tsushida, T., Yamaki, K., & Kobori, M. (2003). Induction of apoptosis in cancer cells by Bilberry (Vaccinium myrtillus) and the anthocyanins. Journal of Agricultural and Food Chemistry, 51, 68-75.
209. Bagchi, D., Sen, C. K., Bagchi, M., & Atala, M. (2004). Antiangiogenic, antioxidant, and anti-carcinogenic properties of a novel anthocyanin-rich berry extract formula. Biochemistry (Mosc), 69, 75-80.
210. Nagase, H., Sasaki, K., Kito, H., Haga, A., & Sato, T. (1998). Inhibitory effect of delphinidin from Solanum melongena on human fibrosarcoma HT-1080 invasiveness in vitro. Planta Medica, 64, 216-219.
211. Chen, P. N., Chu, S. C., Chiou, H. L., Kuo, W. H., Chiang, C. L., & Hsieh, Y. S. (2006). Mulberry anthocyanins, cyanidin 3-rutinoside and cyanidin 3-glucoside, exhibited an inhibitory effect on the migration and invasion of a human lung cancer cell line. Cancer Letters, 235, 248-259.
212. Shin, D. Y., Ryu, C. H., Lee, W. S., Kim, D. C., Kim, S. H., Hah, Y. S., Lee, S. J., Shin, S. C., Kang, H. S., & Choi, Y. H. (2009). Induction of apoptosis and inhibition of invasion in human hepatoma cells by anthocyanins from meoru. Annals of the New York Academy of Sciences, 1171, 137-148.
213. Shin, D. Y., Lee, W. S., Kim, S. H., Kim, M. J., Yun, J. W., Lu, J. N., Lee, S. J., Tsoy, I., Kim, H. J., Ryu, C. H., Kim, G. Y., Kang, H. S., Shin, S. C., & Choi, Y. H. (2009). Anti-invasive activity of anthocyanins isolated from Vitis coignetiae in human hepatocarcinoma cells. Journal of Medicinal Food, 12, 967-972.
214. Ho, M. L., Chen, P. N., Chu, S. C., Kuo, D. Y., Kuo,W. H., Chen, J. Y., & Hsieh, Y. S. (2010). Peonidin 3-glucoside inhibits lung cancer metastasis by downregulation of proteinases activities and MAPK pathway. Nutrition and Cancer, 62, 505-516.
215. Syed, D. N., Afaq, F., Sarfaraz, S., Khan, N., Kedlaya, R., Setaluri, V., & Mukhtar, H. (2008). Delphinidin inhibits cell proliferation and invasion via modulation of Met receptor phosphorylation. Toxicology and Applied Pharmacology, 231, 52-60.
216. Xu, M., Bower, K. A., Wang, S., Frank, J. A., Chen, G., Ding, M., Wang, S., Shi, X., Ke, Z., & Luo, J. (2010). Cyanidin-3-glucoside inhibits ethanol-induced invasion of breast cancer cells overexpressing ErbB2. Molecular Cancer, 9, 285.
217. Matchett, M. D., MacKinnon, S. L., Sweeney, M. I., Gottschall-Pass, K. T., & Hurta, R. A. (2005). Blueberry flavonoids inhibit matrix metalloproteinase activity in DU145 human prostate cancer cells. Biochemistry and Cell Biology, 83, 637-643. (Pubitemid 41812841)
218. Matchett,M.D.,MacKinnon, S. L., Sweeney, M. I., Gottschall-Pass, K. T., & Hurta, R. A. (2006). Inhibition of matrix metalloproteinase activity in DU145 human prostate cancer cells by flavonoids from lowbush blueberry (Vaccinium angustifolium): Possible roles for protein kinase C and mitogen-activated protein-kinase-mediated events. The Journal of Nutritional Biochemistry, 17, 117-125. (Pubitemid 43082146)
219. Yun, J.W., Lee,W. S., Kim, M. J., Lu, J. N., Kang, M. H., Kim, H. G., Kim, D. C., Choi, E. J., Choi, J. Y., Kim, H. G., Lee, Y. K., Ryu,C. H., Kim, G., Choi, Y. H., Park, O. J., & Shin, S. C. (2010). Characterization of a profile of the anthocyanins isolated from Vitis coignetiae Pulliat and their anti-invasive activity on HT-29 human colon cancer cells. Food and Chemical Toxicology, 48, 903-909.
220. Shin, D. Y., Lu, J. N., Kim, G. Y., Jung, J. M., Kang, H. S., Lee, W. S., & Choi, Y. H. (2011). Anti-invasive activities of anthocyanins through modulation of tight junctions and suppression of matrix metalloproteinase activities in HCT-116 human colon carcinoma cells. Oncology Reports, 25, 567-572.
221. Chen, P. N., Kuo, W. H., Chiang, C. L., Chiou, H. L., Hsieh, Y. S., & Chu, S. C. (2006). Black rice anthocyanins inhibit cancer cells invasion via repressions of MMPs and u-PA expression. Chemico-Biological Interactions, 163, 218-229.
222. Lamy, S., Lafleur, R., Bédard, V., Moghrabi, A., Barrette, S., Gingras, D., & Béliveau, R. (2007). Anthocyanidins inhibit migration of glioblastoma cells: Structure-activity relationship and involvement of the plasminolytic system. Journal of Cellular Biochemistry, 100, 100-111. (Pubitemid 44958182)
223. Shankar, S., Ganapathy, S., Hingorani, S. R., & Srivastava, R. K. (2008). EGCG inhibits growth, invasion, angiogenesis and metastasis of pancreatic cancer. Frontiers in Bioscience, 13, 440-452. (Pubitemid 351599756)
224. Pfeffer, U., Ferrari, N., Dell'Eva, R., Indraccolo, S., Morini, M., Noonan, D. M., & Albini, A. (2005). Molecular mechanisms of action of angiopreventive anti-oxidants on endothelial cells: Microarray gene expression analyses. Mutation Research, 591, 198-211. (Pubitemid 41654849)
225. Yamakawa, S., Asai, T., Uchida, T., Matsukawa, M., Akizawa, T., & Oku, N. (2004). (-)-Epigallocatechin gallate inhibits membrane-type 1 matrix metalloproteinase, MT1-MMP, and tumor angiogenesis. Cancer Letters, 210, 47-55. (Pubitemid 38692587)
226. Iishi, H., Tatsuta, M., Baba, M., Yano, H., Sakai, N., & Akedo, H. (2000). Genistein attenuates peritonealmetastasis of azoxymethaneinduced intestinal adenocarcinomas in Wistar rats. International Journal of Cancer, 86, 416-420. (Pubitemid 30187504)
227. Lakshman,M., Xu, L., Ananthanarayanan,V., Cooper, J., Takimoto, C.H.,Helenowski, I., Pelling, J. C.,&Bergan, R. C. (2008). Dietary genistein inhibits metastasis of human prostate cancer in mice. Cancer Research, 68, 2024-2032. (Pubitemid 351416590)
228. Singh, A. V., Franke, A. A., Blackburn, G. L., & Zhou, J. R. (2006). Soy phytochemicals prevent orthotopic growth and metastasis of bladder cancer in mice by alterations of cancer cell proliferation and apoptosis and tumor angiogenesis. Cancer Research, 66, 1851-1858. (Pubitemid 43259972)
229. Singh, R. P., Raina, K., Sharma, G., & Agarwal, R. (2008). Silibinin inhibits established prostate tumor growth, progression, invasion, and metastasis and suppresses tumor angiogenesis and epithelial-mesenchymal transition in transgenic adenocarcinoma of the mouse prostate model mice. Clinical Cancer Research, 14, 7773-7780.
230. Raina, K., Rajamanickam, S., Singh, R. P., Deep, G., Chittezhath, M., & Agarwal, R. (2008). Stage-specific inhibitory effects and associated mechanisms of silibinin on tumor progression and metastasis in transgenic adenocarcinoma of the mouse prostate model. Cancer Research, 68, 6822-6830.
231. Singh, R. P., Dhanalakshmi, S., Agarwal, C., & Agarwal, R. (2005). Silibinin strongly inhibits growth and survival of human endothelial cells via cell cycle arrest and downregulation of survivin, Akt and NF-kappaB: Implications for angioprevention and antiangiogenic therapy. Oncogene, 24, 1188-1202. (Pubitemid 40313920)
232. Devipriya, S., Ganapathy, V., & Shyamaladevi, C. S. (2006). Suppression of tumor growth and invasion in 9,10 dimethyl benz(a) anthracene induced mammary carcinoma by the plant bioflavonoid quercetin. Chemico-Biological Interactions, 162, 106-113. (Pubitemid 44189958)
233. Tan, W. F., Lin, L. P., Li, M. H., Zhang, Y. X., Tong, Y. G., Xiao, D., & Ding, J. (2003). Quercetin, a dietary-derived flavonoid, possesses antiangiogenic potential. European Journal of Pharmacology, 459, 255-262. (Pubitemid 36078329)
234. Tatsuta, A., Iishi, H., Baba,M., Yano, H., Murata, K., Mukai, M., & Akedo, H. (2000). Suppression by apigenin of peritoneal metastasis of intestinal adenocarcinomas induced by azoxymethane in Wistar rats. Clinical & Experimental Metastasis, 18, 657-662.
235. Fang, J., Zhou, Q., Liu, L. Z., Xia, C., Hu, X., Shi, X., & Jiang, B. H. (2007). Apigenin inhibits tumor angiogenesis through decreasing HIF-1alphaand VEGF expression. Carcinogenesis, 28, 858-864. (Pubitemid 46523341)
236. Lentini, A., Forni, C., Provenzano, B., & Beninati, S. (2007). Enhancement of transglutaminase activity and polyamine depletion in B16-F10melanoma cells by flavonoids naringenin and hesperitin correlate to reduction of the in vivo metastatic potential. Amino Acids, 32, 95-100. (Pubitemid 44866573)
237. Ding, M., Feng, R., Wang, S. Y., Bowman, L., Lu, Y., Qian, Y., Castranova, V., Jiang, B. H., & Shi, X. (2006). Cyanidin-3-glucoside, a natural product derived from blackberry, exhibits chemopreventive and chemotherapeutic activity. The Journal of Biological Chemistry, 281, 17359-17368.